Neoantigens Market Set to Surge from US$ 470.72M to US$ 5.6B by 2034: A New Era of Precision Cancer Therapy
The Neoantigens Market Insights highlight a rapidly advancing segment within immuno-oncology, driven by the increasing shift toward personalized cancer treatment strategies. Neoantigens, which are tumor-specific mutated proteins recognized by the immune system, have emerged as highly promising targets for next-generation cancer immunotherapies.  Market Overview and Access to Research...
0 Commenti 0 condivisioni 53 Views 0 Anteprima